Variant report

Variant	nsv983859
Chromosome Location	chr14:103839500-103844345
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr14:103844312-103844806	K562	blood:	n/a	n/a
2	ATF3	chr14:103844312-103844717	K562	blood:	n/a	n/a
3	BHLHE40	chr14:103844335-103844922	K562	blood:	n/a	chr14:103844405-103844421
4	CBX3	chr14:103844276-103844860	K562	blood:	n/a	n/a
5	CCNT2	chr14:103844225-103844900	K562	blood:	n/a	n/a
6	CEBPB	chr14:103844341-103844855	K562	blood:	n/a	n/a
7	CEBPD	chr14:103844263-103844902	K562	blood:	n/a	n/a
8	CEBPD	chr14:103844345-103844895	K562	blood:	n/a	n/a
9	CREB1	chr14:103844212-103844961	K562	blood:	n/a	n/a
10	CREB1	chr14:103844295-103844812	K562	blood:	n/a	n/a
11	EGR1	chr14:103844257-103844787	K562	blood:	n/a	n/a
12	EP300	chr14:103844210-103844878	K562	blood:	n/a	n/a
13	EP300	chr14:103838948-103839529	K562	blood:	n/a	n/a
14	EP300	chr14:103844307-103844731	K562	blood:	n/a	n/a
15	GABPA	chr14:103844281-103844790	K562	blood:	n/a	n/a
16	GABPA	chr14:103844258-103844755	K562	blood:	n/a	n/a
17	GATA1	chr14:103844329-103845036	K562	blood:	n/a	chr14:103844533-103844542 chr14:103844531-103844543 chr14:103844533-103844540
18	GATA1	chr14:103843936-103845063	PBDE	blood:	n/a	chr14:103844201-103844211 chr14:103844533-103844542 chr14:103844531-103844543 chr14:103844533-103844540
19	GATA2	chr14:103844309-103844787	K562	blood:	n/a	chr14:103844533-103844542 chr14:103844531-103844543 chr14:103844533-103844540
20	GATA2	chr14:103840357-103840830	SH-SY5Y	brain:	n/a	n/a
21	GATA2	chr14:103844069-103844842	K562	blood:	n/a	chr14:103844201-103844211 chr14:103844533-103844542 chr14:103844531-103844543 chr14:103844533-103844540
22	GATA2	chr14:103844268-103844884	K562	blood:	n/a	chr14:103844533-103844542 chr14:103844531-103844543 chr14:103844533-103844540
23	GATA3	chr14:103840353-103840770	T-47D	breast:	n/a	n/a
24	GATA3	chr14:103840538-103840781	SH-SY5Y	brain:	n/a	n/a
25	HDAC2	chr14:103844339-103844802	K562	blood:	n/a	chr14:103844532-103844541
26	HEY1	chr14:103844308-103844738	K562	blood:	n/a	n/a
27	JUN	chr14:103838852-103839716	K562	blood:	n/a	chr14:103839066-103839076 chr14:103839066-103839076 chr14:103839066-103839076 chr14:103839066-103839076 chr14:103839068-103839079
28	JUND	chr14:103844013-103844849	K562	blood:	n/a	chr14:103844756-103844764
29	MAFK	chr14:103838997-103839560	K562	blood:	n/a	n/a
30	MAX	chr14:103838771-103839526	A549	lung:	n/a	n/a
31	MAX	chr14:103844345-103844867	K562	blood:	n/a	n/a
32	MAZ	chr14:103839440-103839592	K562	blood:	n/a	n/a
33	MXI1	chr14:103840021-103841391	SK-N-SH	brain:	n/a	n/a
34	MYC	chr14:103844252-103844860	K562	blood:	n/a	n/a
35	MYC	chr14:103844345-103844876	K562	blood:	n/a	n/a
36	NR2F2	chr14:103844198-103844984	K562	blood:	n/a	n/a
37	NRF1	chr14:103840241-103841013	SK-N-SH	brain:	n/a	n/a
38	PBX3	chr14:103838839-103839578	SK-N-SH	brain:	n/a	chr14:103839360-103839369
39	PML	chr14:103844322-103844773	K562	blood:	n/a	n/a
40	PML	chr14:103844262-103844893	K562	blood:	n/a	n/a
41	POLR2A	chr14:103844290-103844783	K562	blood:	n/a	n/a
42	POLR2A	chr14:103844300-103844821	K562	blood:	n/a	n/a
43	POLR2A	chr14:103840654-103840808	MCF-7	breast:	n/a	n/a
44	POLR2A	chr14:103844326-103844780	K562	blood:	n/a	n/a
45	POLR2A	chr14:103844269-103844901	K562	blood:	n/a	n/a
46	POLR2A	chr14:103840430-103840926	SK-N-SH	brain:	n/a	n/a
47	POLR2A	chr14:103844306-103844802	K562	blood:	n/a	n/a
48	POLR2A	chr14:103844044-103845735	PBDE	blood:	n/a	n/a
49	RCOR1	chr14:103844011-103844905	K562	blood:	n/a	n/a
50	RCOR1	chr14:103843893-103844897	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr14:103799041..103818802-chr14:103836567..103862153,82	K562	blood:
2	chr14:103838998..103840691-chr14:103845368..103847242,2	MCF-7	breast:
3	chr14:103842907..103844618-chr14:103856003..103857631,2	K562	blood:
4	chr14:103809174..103813493-chr14:103841708..103846208,8	K562	blood:
5	chr14:103837722..103841762-chr14:103842534..103845975,6	K562	blood:
6	chr14:103839087..103841677-chr14:103842534..103845382,4	K562	blood:
7	chr14:103811082..103813632-chr14:103837787..103840211,3	K562	blood:
8	chr14:103799924..103804064-chr14:103842479..103846418,7	K562	blood:
9	chr14:103839137..103840802-chr14:103851117..103853493,2	MCF-7	breast:
10	chr14:103842907..103844441-chr14:103856131..103859041,2	K562	blood:
11	chr14:103800331..103802463-chr14:103838938..103841320,2	K562	blood:
12	chr14:103840813..103842948-chr14:103850567..103853142,2	MCF-7	breast:
13	chr14:103836563..103839985-chr14:103850679..103852849,4	MCF-7	breast:
14	chr14:103819429..103822833-chr14:103836340..103840943,4	MCF-7	breast:
15	chr14:103842274..103847138-chr14:103849021..103854867,7	K562	blood:
16	chr14:103826315..103828477-chr14:103841833..103843424,2	MCF-7	breast:
17	chr14:103833882..103836372-chr14:103843054..103845403,2	K562	blood:
18	chr14:103843587..103846122-chr14:103847414..103850857,4	K562	blood:
19	chr14:103842005..103845736-chr14:103851555..103855967,5	K562	blood:
20	chr14:103841048..103842744-chr14:103842766..103845551,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000243904	TF binding region
ENSG00000272533	chromatin interactions
ENSG00000243904	chromatin interactions
ENSG00000075413	chromatin interactions
ENSG00000100664	chromatin interactions

Extended variants
information (count: 187 )
Associated
traits (count: 90 )

Variant overlapped rSNPs/rCNVs (count:187 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs192660255	chr14:103839511-103839512	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs184551403	chr14:103839545-103839546	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs188240946	chr14:103839565-103839566	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs531705890	chr14:103839632-103839633	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs1885313	chr14:103839636-103839637	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs548336919	chr14:103839662-103839663	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs138650363	chr14:103839668-103839669	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs534451785	chr14:103839671-103839672	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs554510308	chr14:103839674-103839675	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs112480309	chr14:103839688-103839689	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs540057012	chr14:103839698-103839699	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs180722820	chr14:103839713-103839714	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs146990897	chr14:103839744-103839745	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs541806821	chr14:103839748-103839749	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs543254003	chr14:103839762-103839763	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs555110836	chr14:103839775-103839776	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs572009790	chr14:103839810-103839811	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs540897550	chr14:103839831-103839832	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs564055437	chr14:103839859-103839860	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs112500672	chr14:103839865-103839866	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs137997064	chr14:103839882-103839883	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs562993392	chr14:103839896-103839897	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs529189538	chr14:103839966-103839967	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs17616464	chr14:103839998-103839999	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs35273158	chr14:103840022-103840023	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs143566086	chr14:103840026-103840027	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs561888553	chr14:103840037-103840038	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs527711078	chr14:103840068-103840069	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs147139164	chr14:103840158-103840159	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs576997406	chr14:103840194-103840195	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs571199724	chr14:103840218-103840219	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs536720469	chr14:103840244-103840245	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs148180696	chr14:103840262-103840263	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs141154708	chr14:103840270-103840271	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs10151314	chr14:103840271-103840272	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs36063811	chr14:103840287-103840288	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs552931980	chr14:103840291-103840292	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs535163918	chr14:103840312-103840313	Weak transcription Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs189709959	chr14:103840432-103840433	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs571671614	chr14:103840439-103840440	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs553624413	chr14:103840451-103840452	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs534350413	chr14:103840462-103840463	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs10873537	chr14:103840494-103840495	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs150683260	chr14:103840526-103840527	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs543201535	chr14:103840537-103840538	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs181365046	chr14:103840557-103840558	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs186951228	chr14:103840581-103840582	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs73359960	chr14:103840582-103840583	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs140007308	chr14:103840592-103840593	Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs190489674	chr14:103840608-103840609	Weak transcription Active TSS Bivalent/Poised TSS Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:90)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	17053054	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Cancer	17160897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:66 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:103837600-103839600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr14:103837600-103839800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
3	chr14:103837600-103839800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr14:103837600-103840000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr14:103838200-103840000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr14:103838200-103840000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr14:103838400-103839600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr14:103838400-103839600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr14:103838400-103839600	Enhancers	Esophagus	oesophagus
10	chr14:103838400-103839600	Enhancers	Spleen	Spleen
11	chr14:103838400-103839600	Enhancers	HMEC	breast
12	chr14:103838400-103839600	Enhancers	NHDF-Ad	bronchial
13	chr14:103838400-103839600	Enhancers	NHLF	lung
14	chr14:103838400-103839800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr14:103838400-103839800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr14:103838400-103839800	Enhancers	NHEK	skin
17	chr14:103838600-103839600	Enhancers	HUVEC	blood vessel
18	chr14:103838600-103839600	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr14:103838600-103839800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr14:103838600-103839800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr14:103838800-103839600	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr14:103838800-103839600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
23	chr14:103838800-103839600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr14:103838800-103839600	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr14:103838800-103839600	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr14:103838800-103839600	Flanking Active TSS	NH-A	brain
27	chr14:103838800-103839800	Enhancers	K562	blood
28	chr14:103838800-103840000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
29	chr14:103839000-103839600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr14:103839000-103839600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr14:103839000-103839600	Enhancers	H9 Cell Line	embryonic stem cell
32	chr14:103839000-103839600	Enhancers	Hela-S3	cervix
33	chr14:103839200-103839600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
34	chr14:103839200-103839600	Enhancers	HSMM	muscle
35	chr14:103839200-103839600	Flanking Active TSS	Osteobl	bone
36	chr14:103839200-103850800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr14:103839400-103839600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr14:103839400-103839600	Enhancers	A549	lung
39	chr14:103839400-103839600	Bivalent Enhancer	HepG2	liver
40	chr14:103839400-103840400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr14:103839600-103839800	Enhancers	Muscle Satellite Cultured Cells	--
42	chr14:103839600-103839800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr14:103839600-103840400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr14:103839600-103843800	Weak transcription	Monocytes-CD14+_RO01746	blood
45	chr14:103839600-103844200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
46	chr14:103839600-103845200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr14:103839600-103850600	Weak transcription	Esophagus	oesophagus
48	chr14:103839800-103840200	Weak transcription	K562	blood
49	chr14:103839800-103845400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr14:103840200-103841200	Enhancers	K562	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links